05 June 2008 15:46 [Source: ICIS news]
TORONTO (ICIS news)--Switzerland’s chemical and pharmaceutical industry association SGCI Chemie Pharma on Thursday welcomed a vote by the country’s parliament not to allow parallel imports of patented products.
The vote by the Nationalrat against parallel imports would ensure that innovation, a key contributor to the country’s welfare, remained protected, SGCI said.
Proponents of parallel imports had argued that such imports would help reduce product prices which were much higher in ?xml:namespace>
The practice of parallel imports occurs when producers or distributors set different prices for their products in different markets. Pharmaceutical firms are among its most vehement opponents.
To discuss issues facing the chemicals industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|